NCT00004084View on ClinicalTrials.gov

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

May 31, 2002

Conditions
LeukemiaLymphoma
Interventions
RADIATION

indium In 111 LL2 IgG

single dose, intravenous infusion over 30 minutes

RADIATION

yttrium Y 90 epratuzumab

single dose, intravenous infusion over 30 minutes

Trial Locations (2)

19104

University of Pennsylvania Cancer Center, Philadelphia

07103

Garden State Cancer Center, Belleville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Garden State Cancer Center at the Center for Molecular Medicine and Immunology

OTHER

NCT00004084 - Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia | Biotech Hunter | Biotech Hunter